SWTX fundamentals
SpringWorks Therapeutics, Inc. earnings per share and revenue
SWTX earnings per share for the last quarter are -1.04 USD whereas the estimation was -0.71 USD which accounts for -47.07% surprise. Company revenue for the same period amounts to 61.55 M USD despite the estimated figure of 57.16 M USD. Estimated earnings per share for the next quarter are -0.77 USD, and revenue is expected to reach 64.96 M USD. Also watch annual changes over time to get a bigger picture of SWTX earnings per share and revenue dynamics.
Next report date
≈
Report periodQ1 2025
EPS estimate−0.77USD
Revenue estimate64.96 MUSD
EPS
Forecast
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
−1.60
−1.20
−0.80
−0.40
0.00
Reported
Estimate
Currency: USD
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Reported
−1.18
−1.25
−1.27
−1.44
−1.18
−0.54
−0.72
−1.04
—
—
—
—
Estimate
−1.19
−1.26
−1.33
−1.24
−1.17
−1.12
−0.75
−0.71
−0.77
−0.68
−0.57
−0.39
Surprise
+0.64%
+0.89%
+4.54%
−16.44%
−0.70%
+51.62%
+4.47%
−47.07%
—
—
—
—
Revenue
Forecast
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
0.00
30.00 M
60.00 M
90.00 M
120.00 M
Reported
Estimate
Currency: USD
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Reported
0.00
0.00
0.00
5.40 M
21.01 M
59.73 M
49.30 M
61.55 M
—
—
—
—
Estimate
0.00
0.00
0.00
860.19 K
12.07 M
34.42 M
53.28 M
57.16 M
64.96 M
74.18 M
89.57 M
105.37 M
Surprise
—
—
—
+527.77%
+74.06%
+73.55%
−7.47%
+7.67%
—
—
—
—